| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $52K | — | +232.5% |
| R&D Expense | $694K | — | +24.2% |
| SG&A Expense | $1.4M | — | +51.5% |
| Operating Income | -$2.3M | — | -29.5% |
| Net Income | -$2.2M | — | -30.0% |
| EPS (Basic) | -$0.27 | — | +76.1% |
| EPS (Diluted) | -$0.27 | — | +76.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $16.1M | +476.8% | +612.5% |
| Accounts Receivable | $8K | — | — |
| Inventory | $565K | +3.9% | +25.5% |
| Current Assets | $16.8M | +395.8% | +486.7% |
| Total Assets | $19.8M | +212.0% | +220.0% |
| Current Liabilities | $2.4M | +8.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.0M | — | -30.3% |
| Investing Cash Flow | -$200K | — | — |
| Financing Cash Flow | $15.5M | — | +2339.7% |
| +4.8% |
| Total Liabilities | $3.0M | +0.3% | -16.5% |
| Stockholders' Equity | $16.8M | +401.9% | +550.0% |